Immunology

November 2nd, 2016 Peanut epicutaneous immunotherapy (EPIT), using a skin patch, was safe and associated with a modest 50% treatment response after 52 weeks, with the highest responses among younger children, found a US National Institutes of Health-sponsored...
Page 1 of 41234

Thank you for subscribing to MedicalBrief


MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.


Thank you for taking the time to complete the form.